ISSN Print: 000000000
ISSN Online: 000000000 Impact Factor 2023
(Based on Google scholar citation)

DALE VIEW'S Journal of Clinical Pharmacology and Pharmacotherapeutics (DJCP)

Exploring Advancements in Clinical Pharmacology and Pharmacotherapeutics

About the Journal

Dale View's Journal of Clinical Pharmacology and Pharmacotherapeutics aims to bridge the gap between theoretical pharmacology and its real-world applications in medical practice. Covering a broad spectrum of topics within the field, it encompasses various aspects of pharmacology, drug therapy, and their clinical implications. This wide-ranging scope includes studies related to drug interactions, efficacy, safety, pharmacokinetics, pharmacodynamics, and therapeutic interventions. The Journal serves as a platform for individuals to share their insights, research findings, case studies, and advancements in the field.

Journal Particulars
Title DALE VIEW'S Journal of Clinical Pharmacology and Pharmacotherapeutics (DJCP)
Frequency Bi-annual
ISSN Currently applying for Online ISSN
Publisher i-manager Publications
Chief Editor Dr. Thomas Abraham Panavelil
Ph.D., M.S., M.B.A. ,
Professor of Pharmacology at KPCOM & NSUMD
Nova Southeastern University Fort Lauderdale,
United States.
Copyright i-manager Publications
Starting Year 2024
Subject Medical Sciences
Language English
Publication Format Online
Phone No 04652-231675
Email Id
Mobile No 8589005850
Address i-manager Publications, 3/343, Hill View, Town Railway Nagar, Nagercoil - 629001, TamilNadu.

Aims and Scope

Dale View's Journal of Clinical Pharmacology and Pharmacotherapeutics is dedicated to disseminating cutting-edge research and knowledge pertaining to the application of pharmacology principles in the clinical practice of medicine. The journal covers a wide range of topics within Clinical Pharmacology and Pharmacotherapeutics. The journal serves as a platform for researchers, clinicians, pharmacologists, and healthcare professionals to share their insights and findings, thus contributing to the advancement of this critical field. As research progresses, the scope of this field may continue to evolve to address emerging challenges and opportunities in healthcare and drug therapy.

Publication Ethics and Malpractice Statement

We follow stringent publication ethics, and plagiarized papers are not published, and are withdrawn at any stage of the publishing process. Plagiarism is not limited to the Results and Discussion sections; it can involve any part of the manuscript, including figures and tables, in which material is copied from another publication without attestation, reference, or permission.

Publication Ethics & Peer Review Policy

i-manager Publications follow transparent policies right from paper submission to publication through various well defined and time tested processes.

The publisher follows a ‘No Publishing Fee’ policy.

Click Here

Review Procedure

The Journal follows a double-blind peer-review process, in which submitted articles and research papers undergo review by professors and educators in Pharmacy or related fields.

Click here to view the duties of Reviewers

For all copyright related queries contact


Overall Topics Covered

  • Clinical Trials

  • Drug Development

  • Drug Safety Surveillance

  • Pharmacovigilance

  • Therapeutic Drug Monitoring

  • Gene Therapy

  • Pharmacogenetics

  • Polypharmacy

  • Clinical Pharmacokinetics

  • Drug Formulation

  • Pharmacogenomics

  • Adverse Drug Reactions

  • Drug Toxicity

  • Pharmacoepidemiology

  • Personalized Medicine

  • Pharmacodynamics

  • Immunotherapy